Cargando…

596. Clinical outcomes and healthcare utilization in uninsured patients requiring long-term antibiotic therapy

BACKGROUND: Outpatient parenteral antimicrobial therapy (OPAT) is frequently indicated in the management of severe bacterial infections. Uninsured patients may more have difficulties accessing OPAT services (compared to those with a payer source) which can lead to prolonged hospitalizations or early...

Descripción completa

Detalles Bibliográficos
Autores principales: Vo, Daniel, Hamad, Yasir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776733/
http://dx.doi.org/10.1093/ofid/ofaa439.790
_version_ 1783630751015632896
author Vo, Daniel
Hamad, Yasir
author_facet Vo, Daniel
Hamad, Yasir
author_sort Vo, Daniel
collection PubMed
description BACKGROUND: Outpatient parenteral antimicrobial therapy (OPAT) is frequently indicated in the management of severe bacterial infections. Uninsured patients may more have difficulties accessing OPAT services (compared to those with a payer source) which can lead to prolonged hospitalizations or early discharge with potentially suboptimal therapy. We sought to assess disparities in the care of hospitalized, uninsured patients who had an OPAT indication and to examine subsequent clinical outcomes. METHODS: We performed a retrospective analysis of consecutive patients admitted to an academic hospital from 09/01/2018-12/31/2018 who received an infectious diseases consultation and had an index diagnosis of endocarditis (IE), Staphylococcus aureus BSI, or bone and joint infection including osteomyelitis, prosthetic joint infection, and septic arthritis identified by ICD-10 code. Clinical data were collected during index admission; outcomes were followed for up to 30 days after discharge. We examined differences in length of stay (LOS), discharge against medical advice (AMA), and composite outcome of death and readmission at 30 days in uninsured and privately insured patients. RESULTS: Of 104 patients, 66 (63.5%) were privately insured and 38 (36.5%) were uninsured. Baseline clinical characteristics are presented in Table 1. Uninsured patients were younger (40.9 versus 51.4 years, p< 0.001) and more likely to be African American (55.3% versus 19.7%, p< 0.001). Uninsured patients were more likely to leave AMA (18.4% versus 0%, p=0.001), complete shorter duration of IV antibiotics (p=0.001), and receive oral antibiotics at discharge (15.8% versus 3.0%, p=0.049). Length of stay was numerically longer in this group although not significant (15.5 days versus 10 days, p=0.053). Composite outcome of readmission or death from all cause at 30 days was lower in the uninsured group; however, after adjusting for age, the results were not significant (aOR 0.372, 95% CI 0.106-1.297, p=0.121). Table 1. Demographic and clinical characteristics of privately insured and uninsured patients [Image: see text] CONCLUSION: Uninsured patients were more likely to leave AMA, complete shorter duration of IV antibiotics, and receive oral antibiotics at discharge compared with privately insured patients. Thirty-day readmission and death rates were not significantly different among the two groups. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7776733
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77767332021-01-07 596. Clinical outcomes and healthcare utilization in uninsured patients requiring long-term antibiotic therapy Vo, Daniel Hamad, Yasir Open Forum Infect Dis Poster Abstracts BACKGROUND: Outpatient parenteral antimicrobial therapy (OPAT) is frequently indicated in the management of severe bacterial infections. Uninsured patients may more have difficulties accessing OPAT services (compared to those with a payer source) which can lead to prolonged hospitalizations or early discharge with potentially suboptimal therapy. We sought to assess disparities in the care of hospitalized, uninsured patients who had an OPAT indication and to examine subsequent clinical outcomes. METHODS: We performed a retrospective analysis of consecutive patients admitted to an academic hospital from 09/01/2018-12/31/2018 who received an infectious diseases consultation and had an index diagnosis of endocarditis (IE), Staphylococcus aureus BSI, or bone and joint infection including osteomyelitis, prosthetic joint infection, and septic arthritis identified by ICD-10 code. Clinical data were collected during index admission; outcomes were followed for up to 30 days after discharge. We examined differences in length of stay (LOS), discharge against medical advice (AMA), and composite outcome of death and readmission at 30 days in uninsured and privately insured patients. RESULTS: Of 104 patients, 66 (63.5%) were privately insured and 38 (36.5%) were uninsured. Baseline clinical characteristics are presented in Table 1. Uninsured patients were younger (40.9 versus 51.4 years, p< 0.001) and more likely to be African American (55.3% versus 19.7%, p< 0.001). Uninsured patients were more likely to leave AMA (18.4% versus 0%, p=0.001), complete shorter duration of IV antibiotics (p=0.001), and receive oral antibiotics at discharge (15.8% versus 3.0%, p=0.049). Length of stay was numerically longer in this group although not significant (15.5 days versus 10 days, p=0.053). Composite outcome of readmission or death from all cause at 30 days was lower in the uninsured group; however, after adjusting for age, the results were not significant (aOR 0.372, 95% CI 0.106-1.297, p=0.121). Table 1. Demographic and clinical characteristics of privately insured and uninsured patients [Image: see text] CONCLUSION: Uninsured patients were more likely to leave AMA, complete shorter duration of IV antibiotics, and receive oral antibiotics at discharge compared with privately insured patients. Thirty-day readmission and death rates were not significantly different among the two groups. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7776733/ http://dx.doi.org/10.1093/ofid/ofaa439.790 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Vo, Daniel
Hamad, Yasir
596. Clinical outcomes and healthcare utilization in uninsured patients requiring long-term antibiotic therapy
title 596. Clinical outcomes and healthcare utilization in uninsured patients requiring long-term antibiotic therapy
title_full 596. Clinical outcomes and healthcare utilization in uninsured patients requiring long-term antibiotic therapy
title_fullStr 596. Clinical outcomes and healthcare utilization in uninsured patients requiring long-term antibiotic therapy
title_full_unstemmed 596. Clinical outcomes and healthcare utilization in uninsured patients requiring long-term antibiotic therapy
title_short 596. Clinical outcomes and healthcare utilization in uninsured patients requiring long-term antibiotic therapy
title_sort 596. clinical outcomes and healthcare utilization in uninsured patients requiring long-term antibiotic therapy
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776733/
http://dx.doi.org/10.1093/ofid/ofaa439.790
work_keys_str_mv AT vodaniel 596clinicaloutcomesandhealthcareutilizationinuninsuredpatientsrequiringlongtermantibiotictherapy
AT hamadyasir 596clinicaloutcomesandhealthcareutilizationinuninsuredpatientsrequiringlongtermantibiotictherapy